173 related articles for article (PubMed ID: 12386130)
1. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole.
Matsumoto S; Hirama T; Matsubara T; Nagata K; Yamazoe Y
Drug Metab Dispos; 2002 Nov; 30(11):1240-5. PubMed ID: 12386130
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of human small intestinal and liver microsomal astemizole O-demethylation: different contribution of CYP2J2 in the small intestine and liver.
Matsumoto S; Hirama T; Kim HJ; Nagata K; Yamazoe Y
Xenobiotica; 2003 Jun; 33(6):615-23. PubMed ID: 12851038
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes.
Hashizume T; Imaoka S; Mise M; Terauchi Y; Fujii T; Miyazaki H; Kamataki T; Funae Y
J Pharmacol Exp Ther; 2002 Jan; 300(1):298-304. PubMed ID: 11752129
[TBL] [Abstract][Full Text] [Related]
4. Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine.
Wang MZ; Wu JQ; Bridges AS; Zeldin DC; Kornbluth S; Tidwell RR; Hall JE; Paine MF
Drug Metab Dispos; 2007 Nov; 35(11):2067-75. PubMed ID: 17709372
[TBL] [Abstract][Full Text] [Related]
5. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A.
Liu KH; Kim MG; Lee DJ; Yoon YJ; Kim MJ; Shon JH; Choi CS; Choi YK; Desta Z; Shin JG
Drug Metab Dispos; 2006 Nov; 34(11):1793-7. PubMed ID: 16896065
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel substrates for human cytochrome P450 2J2.
Lee CA; Neul D; Clouser-Roche A; Dalvie D; Wester MR; Jiang Y; Jones JP; Freiwald S; Zientek M; Totah RA
Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation.
Park SH; Lee J; Shon JC; Phuc NM; Jee JG; Liu KH
Phytomedicine; 2018 Mar; 42():199-206. PubMed ID: 29655687
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome
Uno Y; Murayama N; Ijiri M; Kawaguchi H; Yamato O; Shiraishi M; Asano A; Teraoka H; Mizukawa H; Nakayama SMM; Ikenaka Y; Ishizuka M; Yamazaki H
Drug Metab Dispos; 2022 Nov; 50(11):1434-1441. PubMed ID: 35701183
[TBL] [Abstract][Full Text] [Related]
10. CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance.
Zeldin DC; Foley J; Goldsworthy SM; Cook ME; Boyle JE; Ma J; Moomaw CR; Tomer KB; Steenbergen C; Wu S
Mol Pharmacol; 1997 Jun; 51(6):931-43. PubMed ID: 9187259
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity.
Lee SS; Jeong HE; Liu KH; Ryu JY; Moon T; Yoon CN; Oh SJ; Yun CH; Shin JG
Pharmacogenet Genomics; 2005 Feb; 15(2):105-13. PubMed ID: 15861034
[TBL] [Abstract][Full Text] [Related]
12. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
Lee E; Wu Z; Shon JC; Liu KH
Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
[TBL] [Abstract][Full Text] [Related]
13. A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine.
Hashizume T; Mise M; Matsumoto S; Terauchi Y; Fujii T; Imaoka S; Funae Y; Kamataki T; Miyazaki H
Drug Metab Dispos; 2001 Jun; 29(6):798-805. PubMed ID: 11353747
[TBL] [Abstract][Full Text] [Related]
14. Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine.
Matsumoto S; Yamazoe Y
Br J Clin Pharmacol; 2001 Feb; 51(2):133-42. PubMed ID: 11259984
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart.
Wu S; Moomaw CR; Tomer KB; Falck JR; Zeldin DC
J Biol Chem; 1996 Feb; 271(7):3460-8. PubMed ID: 8631948
[TBL] [Abstract][Full Text] [Related]
16. Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations.
Yamazaki H; Okayama A; Imai N; Guengerich FP; Shimizu M
Xenobiotica; 2006 Dec; 36(12):1201-9. PubMed ID: 17162467
[TBL] [Abstract][Full Text] [Related]
17. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
[TBL] [Abstract][Full Text] [Related]
18. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
Lalovic B; Phillips B; Risler LL; Howald W; Shen DD
Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299
[TBL] [Abstract][Full Text] [Related]
19. Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes.
Lee E; Kim JH; Shon JC; Wu Z; Kim HJ; Gim M; Lee T; Liu KH
Drug Metab Pharmacokinet; 2018 Jun; 33(3):159-163. PubMed ID: 29759885
[TBL] [Abstract][Full Text] [Related]
20. Marmoset cytochrome P450 2J2 mainly expressed in small intestines and livers effectively metabolizes human P450 2J2 probe substrates, astemizole and terfenadine.
Uehara S; Uno Y; Inoue T; Okamoto E; Sasaki E; Yamazaki H
Xenobiotica; 2016 Nov; 46(11):977-85. PubMed ID: 26899760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
